We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Life Sciences/Propolis: Research, Apitherapy and Clinical Applications
PeriodicalsLife Sciences

Propolis: Research, Apitherapy and Clinical Applications

Apis2026

Checking your access to this record.

Abstract & Overview

Background The literature shows that propolis has been widely used in the treatment of inflammatory diseases and wound healing for centuries. Objective The aim of this paper is to present the key findings from in vitro and in vivo assays, as well as clinical trials, involving propolis. Methods Publications related to research conducted in vitro using different cell cultures, and in vivo using mice and other experimental animals, were examined. Clinical trials involving propolis were also analysed. Results Literature revealed the significant antimicrobial, anti-inflammatory and antitumor effects of propolis, either on its own or when combined with medicines, indicating its efficiency and usefulness. The pharmacological activities of propolis demonstrate its potential as an adjuvant or alternative to conventional drugs, either on its own or in combination with drugs commonly used to treat various diseases. Conclusion The in vitro and in vivo assays allowed for the conducting of clinical trials, which confirmed the benefits of propolis for human health.

Cite this record

José Maurício Sforcin (2026). Propolis: Research, Apitherapy and Clinical Applications. Apis, 3(1), 38–41. https://doi.org/10.62949/03907046.4931149

Copy in another style

Sforcin, J. M. (2026). Propolis: Research, Apitherapy and Clinical Applications. Apis, 3(1), 38–41. https://doi.org/10.62949/03907046.4931149
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.